Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization

Toxicology in Vitro

Volumn 22, Issue 6, 2008, Pages 1419-1431

  Verstraelen, S ^a   Bloemen, K ^a   Nelissen, I ^a   Witters, H ^a   Schoeters, G ^a   Heuvel, R Van Den ^a  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

Author keywords

Allergic asthma; In vitro models; Occupational asthma; Respiratory sensitization

Indexed keywords

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; BASOPHIL; CELL STRUCTURE; CELL TYPE; CLINICAL ASSESSMENT; DENDRITIC CELL; DISEASE COURSE; EOSINOPHIL; HAZARD ASSESSMENT; HUMAN; IN VITRO STUDY; MACROPHAGE; MAST CELL; NEUTROPHIL; OCCUPATIONAL ASTHMA; RESPIRATORY SYSTEM; REVIEW; SENSITIZATION; T LYMPHOCYTE;

ALLERGENS; ANIMALS; ASTHMA; HUMANS; MODELS, BIOLOGICAL; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RESPIRATORY SYSTEM;

EID: 49149107693     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.05.008     Document Type: Review

References (214)

1. Alberts W.M., and do Pico G.A. Reactive airways dysfunction syndrome. Chest 109 (1996) 1618-1626
2. Ammit A.J., Bekir S.S., Johnson P.R., Hughes J.M., Armour C.L., and Black J.L. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am. J. Respir. Crit. Care Med. 155 (1997) 1123-1129
3. Aoshiba K., and Nagai A. Oxidative stress, cell death, and other damage to alveolar epithelial cells induced by cigarette smoke. Tobacco Induced Diseases 1 3 (2003) 219-226
4. Arts J.H., and Kuper C.F. Animal models to test respiratory allergy of low molecular weight chemicals: a guidance. Methods 41 (2007) 61-71
5. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., Miyazawa M., Ito Y., Suzuki H., and Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 20 (2006) 767-773
6. Aufderheide M., Knebel J.W., and Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp. Toxicol. Pathol. 55 (2003) 51-57
7. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47 (1991) 22-31
8. Azam P., Peiffer J.L., Chamousset D., Tissier M.H., Bonnet P.A., Vian L., Fabre I., and Ourlin J.C. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol. Appl. Pharmacol. 212 (2006) 14-23
9. Bacharier L.B., and Geha R.S. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 105 (2000) S547-S558
10. Banks D.E. Workplace irritant exposures: do they produce true occupational asthma?. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 163-168
11. Banks D.E., and Jalloul A. Occupational asthma, work-related asthma and reactive airways dysfunction syndrome. Curr. Opin. Pulm. Med. 13 (2007) 131-136
12. Baraniuk J.N. Pathogenesis of allergic rhinitis. J. Allergy Clin. Immunol. 99 (1997) S763-S772
13. Bardana Jr. E.J. Reactive airways dysfunction syndrome (RADS): fact or fantasy?. Allergy 54 Suppl. 58 (1999) 33-35
14. Barnes P.J., Chung K.F., and Page C.P. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50 (1998) 515-596
15. Basketter D., and Maxwell G. In vitro approaches to the identification and characterization of skin sensitizers. Cutan. Ocul. Toxicol. 26 (2007) 359-373
16. Baur X., and Czuppon A. Diagnostic validation of specific IgE antibody concentrations, skin prick testing, and challenge tests in chemical workers with symptoms of sensitivity to different anhydrides. J. Allergy Clin. Immunol. 96 (1995) 489-494
17. Berger J.T., Voynow J.A., Peters K.W., and Rose M.C. Respiratory carcinoma cell lines. MUC genes and glycoconjugates. Am. J. Respir. Cell Mol. Biol. 20 (1999) 500-510
18. Bergeron C., and Boulet L.P. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 129 (2006) 1068-1087
19. Berges C., Naujokat C., Tinapp S., Wieczorek H., Hoh A., Sadeghi M., Opelz G., and Daniel V. A cell line model for the differentiation of human dendritic cells. Biochem. Biophys. Res. Commun. 333 (2005) 896-907
20. Bernstein D.I. Occupational asthma caused by exposure to low-molecular-weight chemicals. Immunol. Allergy Clin. North Am. 23 (2003) 221-234
21. Bernstein I.L., Chan-Yeung M., and Bernstein D.I. Asthma in the Workplace (2006), Taylor and Francis, New York, NY, USA
22. Bharadwaj A., and Agrawal D.K. Immunomodulation in asthma: a distant dream or a close reality?. Int. Immunopharmacol. 4 (2004) 495-511
23. Biagini R.E., Bernstein I.L., Gallagher J.S., Moorman W.J., Brooks S., and Gann P.H. The diversity of reaginic immune responses to platinum and palladium metallic salts. J. Allergy Clin. Immunol. 76 (1985) 794-802
24. Black J.L., and Johnson P.R. Factors controlling smooth muscle proliferation and airway remodelling. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 47-51
25. Blanc P.D., and Toren K. How much adult asthma can be attributed to occupational factors?. Am. J. Med. 107 (1999) 580
26. Bloemen K., Verstraelen S., Van Den Heuvel R., Witters H., Nelissen I., and Schoeters G. The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol. Lett. 113 (2007) 6-18
27. Bocchietto E., Paolucci C., Breda D., Sabbioni E., and Burastero S.E. Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals. Int. J. Immunopathol. Pharmacol. 20 (2007) 259-265
28. Bochner B.S., and Busse W.W. Advances in mechanisms of allergy. J. Allergy Clin. Immunol. 113 (2004) 868-875
29. Botham P.A., Hext P.M., Rattray N.J., Walsh S.T., and Woodcock D.R. Sensitisation of guinea pigs by inhalation exposure to low molecular weight chemicals. Toxicol. Lett. 41 (1988) 159-173
30. Botham P.A., Rattray N.J., Woodcock D.R., Walsh S.T., and Hext P.M. The induction of respiratory allergy in guinea-pigs following intradermal injection of trimellitic anhydride: a comparison with the response to 2,4-dinitrochlorobenzene. Toxicol. Lett. 47 (1989) 25-39
31. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161 (2000) 1720-1745
32. Boverhof D.R., Billington R., Gollapudi B.B., Hotchkiss J.A., Krieger S.M., Poole A., Wiescinski C.M., and Woolhiser M.R. Respiratory sensitization and allergy: current research approaches and needs. Toxicol. Appl. Pharmacol. 226 (2008) 1-13
33. Bradding P., and Holgate S.T. Immunopathology and human mast cell cytokines. Crit. Rev. Oncol. Hematol. 31 (1999) 119-133
34. Bradding P., Walls A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117 (2006) 1277-1284
35. Brewster C.E., Howarth P.H., Djukanovic R., Wilson J., Holgate S.T., and Roche W.R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3 (1990) 507-511
36. Brightling C.E., Symon F.A., Birring S.S., Bradding P., Pavord I.D., and Wardlaw A.J. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 110 (2002) 899-905
37. Brooks S.M., Hammad Y., Richards I., Giovinco-Barbas J., and Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 113 (1998) 42-49
38. Brooks S.M., Weiss M.A., and Bernstein I.L. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 88 (1985) 376-384
39. Burgess J.K., Carlin S., Pack R.A., Arndt G.M., Au W.W., Johnson P.R., Black J.L., and Hunt N.H. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?. J. Allergy Clin. Immunol. 113 (2004) 683-689
40. Busse W.W., and Lemanske Jr. R.F. Asthma. New Engl. J. Med. 344 (2001) 350-362
41. Carraway M.S., and Piantadosi C.A. Acute Lung Injury in Response to Toxicological Exposures (1999), Taylor and Francis, Philadelphia
42. Carroll N.G., Mutavdzic S., and James A.L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J. 19 (2002) 879-885
43. Carterson A.J., Honer zu Bentrup K., Ott C.M., Clarke M.S., Pierson D.L., Vanderburg C.R., Buchanan K.L., Nickerson C.A., and Schurr M.J. A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect. Immun. 73 (2005) 1129-1140
44. Chan-Yeung M., and Malo J.L. Aetiological agents in occupational asthma. Eur. Respir. J. 7 (1994) 346-371
45. Chang-Yeung M., and Lam S. Occupational asthma. Am. Rev. Respir. Dis. 133 (1986) 686-703
46. Chang T.W., Davis F.M., Sun N.C., Sun C.R., MacGlashan Jr. D.W., and Hamilton R.G. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (NY) 8 (1990) 122-126
47. Christodoulopoulos P., Cameron L., Nakamura Y., Lemiere C., Muro S., Dugas M., Boulet L.P., Laviolette M., Olivenstein R., and Hamid Q. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J. Allergy Clin. Immunol. 107 (2001) 586-591
48. Chung K.F., and Barnes P.J. Cytokines in asthma. Thorax 54 (1999) 825-857
49. COM, 2001. 88final White Book, Strategy for Future Chemicals Policy. (C. o. t. E. Communities, Ed.).
50. Constant S.L., Brogdon J.L., Piggott D.A., Herrick C.A., Visintin I., Ruddle N.H., and Bottomly K. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110 (2002) 1441-1448
51. Contreras G.R., Rousseau R., and Chan-Yeung M. Occupational respiratory diseases in British Columbia, Canada in 1991. Occup. Environ. Med. 51 (1994) 710-712
52. Cozens A.L., Yezzi M.J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W.E., Widdicombe J.H., and Gruenert D.C. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10 (1994) 38-47
53. Cromwell O., Pepys J., Parish W.E., and Hughes E.G. Specific IgE antibodies to platinum salts in sensitized workers. Clin. Allergy 9 (1979) 109-117
54. Davies D.E., Wicks J., Powell R.M., Puddicombe S.M., and Holgate S.T. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 111 (2003) 215-225
55. De Smedt A.C., Van Den Heuvel R.L., Van Tendeloo V.F., Berneman Z.N., Schoeters G.E., Weber E., and Tuschl H. Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis. Arch. Dermatol. Res. 294 (2002) 109-116
56. De Smedt A.C., Van Den Heuvel R.L., Zwi Berneman N., and Schoeters G.E. Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. Toxicol. In Vitro 15 (2001) 319-325
57. Dearman R.J., Betts C.J., Humphreys N., Flanagan B.F., Gilmour N.J., Basketter D.A., and Kimber I. Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol. Sci. 71 (2003) 137-145
58. Dearman R.J., and Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J. Appl. Toxicol. 21 (2001) 153-163
59. Debes G.F., Arnold C.N., Young A.J., Krautwald S., Lipp M., Hay J.B., and Butcher E.C. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6 (2005) 889-894
60. Deschamps F., Prevost A., Lavaud F., and Kochman S. Mechanisms of occupational asthma induced by isocyanates. Ann. Occup. Hyg. 42 (1998) 33-36
61. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., and Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
62. Elias J.A. Airway remodeling in asthma. Unanswered questions. Am. J. Respir. Crit. Care Med. 161 (2000) S168-S171
63. Elias J.A., Zhu Z., Chupp G., and Homer R.J. Airway remodeling in asthma. J. Clin. Invest. 104 (1999) 1001-1006
64. Elms J., Beckett P.N., Griffin P., and Curran A.D. Mechanisms of isocyanate sensitisation. An in vitro approach. Toxicol. In Vitro 15 (2001) 631-634
65. Epstein M.M. Targeting memory Th2 cells for the treatment of allergic asthma. Pharmacol. Ther. 109 (2006) 107-136
66. Erlemann K.R., Cossette C., Gravel S., Lesimple A., Lee G.J., Saha G., Rokach J., and Powell W.S. Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress. Free Radic. Biol. Med. 42 (2007) 654-664
67. Fedorowicz A., Singh H., Soderholm S., and Demchuk E. Structure-activity models for contact sensitization. Chem. Res. Toxicol. 18 (2005) 954-969
68. Finotto S., Fabbri L.M., Rado V., Mapp C.E., and Maestrelli P. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br. J. Ind. Med. 48 (1991) 116-121
69. Folkerts G., and Nijkamp F.P. Airway epithelium: more than just a barrier!. Trends Pharmacol. Sci. 19 (1998) 334
70. Foster P.S., Mould A.W., Yang M., Mackenzie J., Mattes J., Hogan S.P., Mahalingam S., McKenzie A.N., Rothenberg M.E., Young I.G., Matthaei K.I., and Webb D.C. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179 (2001) 173-181
71. Gad S.C., Dunn B.J., Dobbs D.W., Reilly C., and Walsh R.D. Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol. Appl. Pharmacol. 84 (1986) 93-114
72. Galli S.J., Metcalfe D.D., and Dvorak A.M. Basophils and Mast cells and their disorders. In: Beutler E., Lichtman M.A., Coller B.S., Kipps T.J., and Seligssohn U. (Eds). Williams Hematology. sixth ed. (2001), McGraw-Hill, New York 801-815
73. Garssen J., Nijkamp F.P., Van Vugt E., Van der Vliet H., and Van Loveren H. T cell-derived antigen binding molecules play a role in the induction of airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 150 (1994) 1528-1538
74. Gerberick G.F., Ryan C.A., Kern P.S., Schlatter H., Dearman R.J., Kimber I., Patlewicz G.Y., and Basketter D.A. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 16 (2005) 157-202
75. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., and Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 97 (2007) 417-427
76. Gildea L.A., Ryan C.A., Foertsch L.M., Kennedy J.M., Dearman R.J., Kimber I., and Gerberick G.F. Identification of gene expression changes induced by chemical allergens in dendritic cells: opportunities for skin sensitization testing. J. Invest. Dermatol. 126 (2006) 1813-1822
77. Goldsby R.A., Kindt T.J., and Osborne B.A. Kuby Immunology (2000), Freeman, W.H. and company, New York
78. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., and Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189 (1999) 451-460
79. Graham C., Rosenkranz H.S., and Karol M.H. Structure-activity model of chemicals that cause human respiratory sensitization. Regul. Toxicol. Pharmacol. 26 (1997) 296-306
80. Hammad H., Smits H.H., Ratajczak C., Nithiananthan A., Wierenga E.A., Stewart G.A., Jacquet A., Tonnel A.B., and Pestel J. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. Eur. Cytokine. Netw. 14 (2003) 219-228
81. Hamzaoui A., Hamzaoui K., Salah H., and Chabbou A. Lymphocytes apoptosis in patients with acute exacerbation of asthma. Mediators Inflamm. 8 (1999) 237-243
82. Hart P.H. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 79 (2001) 149-153
83. Hayashi M., Higashi K., Kato H., and Kaneko H. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c. Toxicol. Appl. Pharmacol. 177 (2001) 38-45
84. Herrick C.A., Das J., Xu L., Wisnewski A.V., Redlich C.A., and Bottomly K. Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: Genetic control of TH2-induced lung inflammation. J. Allergy Clin. Immunol. 111 (2003) 1087
85. Hilton J., Dearman R.J., Boylett M.S., Fielding I., Basketter D.A., and Kimber I. The mouse IgE test for the identification of potential chemical respiratory allergens: considerations of stability and controls. J. Appl. Toxicol. 16 (1996) 165-170
86. Hirota M., and Moro O. MIP-1beta, a novel biomarker for in vitro sensitization test using human monocytic cell line. Toxicol. In Vitro 20 (2006) 736-742
87. Holsapple M.P., Jones D., Kawabata T.T., Kimber I., Sarlo K., Selgrade M.K., Shah J., and Woolhiser M.R. Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 91 (2006) 4-13
88. Holsapple M.P., Jones D., Kawabata T.T., Kimber I., Sarlo K., Selgrade M.K., Shah J., and Woolhiser M.R. Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 91 (2006) 4-13
89. Holt P.G. Antigen presentation in the lung. Am. J. Respir. Crit. Care Med. 162 (2000) S151-S156
90. Huang J., Olivenstein R., Taha R., Hamid Q., and Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am. J. Respir. Crit. Care Med. 160 (1999) 725-729
91. Hulette B.A., Ryan C.A., and Gerberick G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol. Appl. Pharmacol. 182 (2002) 226-233
92. Hulette B.C., Ryan C.A., Gildea L.A., and Gerberick G.F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicol. Appl. Pharmacol. 209 (2005) 159-166
93. Ishii H., Hayashi S., Hogg J.C., Fujii T., Goto Y., Sakamoto N., Mukae H., Vincent R., and van Eeden S.F. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir. Res. 6 (2005) 87
94. Janeway C., Travers P., Hunt S., and Walport M. Immunobiology: The Immune System in Health and Disease (1997), Garland Publishing, New York
95. Jenkins H.A., Cool C., Szefler S.J., Covar R., Brugman S., Gelfand E.W., and Spahn J.D. Histopathology of severe childhood asthma: a case series. Chest 124 (2003) 32-41
96. Jenkins H.S., Devalia J.L., Mister R.L., Bevan A.M., Rusznak C., and Davies R.J. The effect of exposure to ozone and nitrogen dioxide on the airway response of atopic asthmatics to inhaled allergen: dose- and time-dependent effects. Am. J. Respir. Crit. Care Med. 160 (1999) 33-39
97. Johnson S.R., and Knox A.J. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18 (1997) 288-292
98. Jowsey I.R., Basketter D.A., Westmoreland C., and Kimber I. A future approach to measuring relative skin sensitising potency: a proposal. J. Appl. Toxicol. 26 (2006) 341-350
99. Julia V., Hessel E.M., Malherbe L., Glaichenhaus N., O'Garra A., and Coffman R.L. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16 (2002) 271-283
100. Karol M.H. Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure. Toxicol. Appl. Pharmacol. 68 (1983) 229-241
101. Kawabori S., Kanai N., and Tosho T. Proliferative activity of mast cells in allergic nasal mucosa. Clin. Exp. Allergy 25 (1995) 173-178
102. Kay A.B., and Klion A.D. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Immunol. Allergy Clin. North Am. 24 (2004) 645-666
103. Kay A.B., and Klion A.D. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Immunol. Allergy Clin. North Am. 24 (2004) 645-666 (vii)
104. Ke Y., Reddel R.R., Gerwin B.I., Miyashita M., McMenamin M., Lechner J.F., and Harris C.C. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 38 (1988) 60-66
105. Kimber I., and Dearman R.J. The mechanisms and evaluation of chemically induced allergy. Toxicol. Lett. (1992) 79-84
106. Kimber I., and Dearman R.J. Toxicology of Chemical Respiratory Hypersensitivity (1997), Taylor and Francis, London, UK
107. Kogevinas M., Zock J.P., Jarvis D., Kromhout H., Lillienberg L., Plana E., Radon K., Toren K., Alliksoo A., Benke G., Blanc P.D., Dahlman-Hoglund A., D'Errico A., Hery M., Kennedy S., Kunzli N., Leynaert B., Mirabelli M.C., Muniozguren N., Norback D., Olivieri M., Payo F., Villani S., van Sprundel M., Urrutia I., Wieslander G., Sunyer J., and Anto J.M. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 370 (2007) 336-341
108. Kohro T., Tanaka T., Murakami T., Wada Y., Aburatani H., Hamakubo T., and Kodama T. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J. Atheroscler. Thromb. 11 (2004) 88-97
109. Kopferschmitt-Kubler M.C., Ameille J., Popin E., Calastreng-Crinquand A., Vervloet D., Bayeux-Dunglas M.C., and Pauli G. Occupational asthma in France: a 1-yr report of the observatoire National de Asthmes Professionnels project. Eur. Respir. J. 19 (2002) 84-89
110. Krakauer T. Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology 46 (2000) 253-261
111. Kwong K.Y.C., Literat A., Zhu N.L., Huang H.H., Li C., Jones C.A., and Minoo P. Expression of transforming growth factor beta (TGF-[beta]1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway. Life Sciences 74 (2004) 2941-2957
112. Laberge S., and El Bassam S. Cytokines, structural cells of the lungs and airway inflammation. Paediatr. Respir. Rev. 5 (2004) S41-S45
113. Lambrecht B.N., Salomon B., Klatzmann D., and Pauwels R.A. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160 (1998) 4090-4097
114. Lampinen M., Carlson M., Hakansson L.D., and Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59 (2004) 793-805
115. Lang D.S., Jorres R.A., Mucke M., Siegfried W., and Magnussen H. Interactions between human bronchoepithelial cells and lung fibroblasts after ozone exposure in vitro. Toxicol. Lett. (1998) 13-97
116. Lang D.S., Schocker H., and Hockertz S. Effects of crocidolite asbestos on human bronchoepithelial-dependent fibroblast stimulation in coculture: the role of IL-6 and GM-CSF. Toxicol 159 (2001) 81-98
117. Larche M., Robinson D.S., and Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111 (2003) 450-463
118. Lee Y.M., Kim H.A., Park H.S., Lee S.K., and Nahm D.H. Exposure to toluene diisocyanate (TDI) induces IL-8 production from bronchial epithelial cells: effect of pro-inflammatory cytokines. J. Korean Med. Sci. 18 (2003) 809-812
119. Lipscomb M.F., and Masten B. Dendritic cells: immune regulators in health and disease. J. Physiol. Rev. 82 (2002) 97-130
120. MacGlashan Jr. D.W., Bochner B.S., Adelman D.C., Jardieu P.M., Togias A., McKenzie-White J., Sterbinsky S.A., Hamilton R.G., and Lichtenstein L.M. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158 (1997) 1438-1445
121. Maestrelli P., Del Prete G.F., De Carli M., D'Elios M.M., Saetta M., Di Stefano A., Mapp C.E., Romagnani S., and Fabbri L.M. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand. J. Work Environ. Health 20 (1994) 376-381
122. Magnusson B., and Kligman A.M. The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Dermatol. 52 (1969) 268-276
123. Malo J.L., and Chan-Yeung M. Occupational asthma. J. Allergy Clin. Immunol. 108 (2001) 317-328
124. Malo J.L., Ghezzo H., D'Aquino C., L'Archeveque J., Cartier A., and Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J. Allergy Clin. Immunol. 90 (1992) 937-944
125. Manetz T.S., Pettit D.A., and Meade B.J. The determination of draining lymph node cell cytokine mRNA levels in BALB/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure. Toxicol. Appl. Pharmacol. 171 (2001) 174-183
126. Mapp C., Boschetto P., Miotto D., De Rosa E., and Fabbri L.M. Mechanisms of occupational asthma. Ann. Allergy Asthma Immunol. 83 (1999) 645-664
127. Mapp C.E. Agents, old and new, causing occupational asthma. Occup. Environ. Med. 58 (2001) 354-360 290
128. Mapp C.E., Boschetto P., Maestrelli P., and Fabbri L.M. Occupational asthma. Am. J. Respir. Crit. Care Med. 172 (2005) 280-305
129. Mapp C.E., Polato R., Maestrelli P., Hendrick D.J., and Fabbri L.M. Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects. J. Allergy Clin. Immunol. 75 (1985) 568-572
130. Marone G., Triggiani M., and de Paulis A. Mast cells and basophils: friends as well as foes in bronchial asthma?. Trends Immunol. 26 (2005) 25-31
131. Masterson A.J., Sombroek C.C., De Gruijl T.D., Graus Y.M., van der Vliet H.J., Lougheed S.M., van den Eertwegh A.J., Pinedo H.M., and Scheper R.J. MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood 100 (2002) 701-703
132. Matsukura S., Kokubu F., Kuga H., Kawaguchi M., Ieki K., Odaka M., Suzuki S., Watanabe S., Takeuchi H., and Adachi M. Differential regulation of eotaxin expression by IFN-[gamma] in airway epithelial cells. J. Allergy Clin. Immunol. 111 (2003) 1337
133. McKay S., Bromhaar M.M., de Jongste J.C., Hoogsteden H.C., Saxena P.R., and Sharma H.S. Pro-inflammatory cytokines induce c-fos expression followed by IL-6 release in human airway smooth muscle cells. Mediators Inflamm. 10 (2001) 135-142
134. Mitjans M., Marinovich M., Lucchi L., Galli C.L., and Corsini E. Role of p38 MAPK in chemical allergen-induced selective production of IL-8 in naive THP-1 cells. Toxicol. Lett. 172 (2007) S86-S87
135. Miyazawa M., Ito Y., Yoshida Y., Sakaguchi H., and Suzuki H. Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol. In Vitro 21 (2007) 428-437
136. Mizuashi M., Ohtani T., Nakagawa S., and Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 124 (2005) 579-586
137. Mogel M., Kruger E., Krug H.F., and Seidel A. A new coculture-system of bronchial epithelial and endothelial cells as a model for studying ozone effects on airway tissue. Toxicol. Lett. (1998) 25-32
138. Moriyuki K., Nagataki M., Sekiguchi F., Nishikawa H., and Kawabata A. Signal transduction for formation/release of interleukin-8 caused by a PAR2-activating peptide in human lung epithelial cells. Regul. Pept. 10 (2007) 42-48
139. Munoz X., Cruz M.J., Orriols R., Bravo C., Espuga M., and Morell F. Occupational asthma due to persulfate salts: diagnosis and follow-up. Chest 123 (2003) 2124-2129
140. Nouri-Aria K.T., Irani A.-M.A., Jacobson M.R., O'Brien F., Varga E.M., Till S.J., Durham S.R., and Schwartz L.B. Basophil recruitment and IL-4 production during human allergen-induced late asthma. J. Allergy Clin. Immunol. 108 (2001) 205-211
141. OECD, 2002. Guideline 429: Skin Sensitization: Local Lymph Node Assay. Organisation for economic co-operation and development guideline for testing of chemicals.
142. Orriols R., Costa R., Albanell M., Alberti C., Castejon J., Monso E., Panades R., Rubira N., and Zock J.P. Reported occupational respiratory diseases in Catalonia. Occup. Environ. Med. 63 (2006) 255-260
143. Ott V.L., Cambier J.C., Kappler J., Marrack P., and Swanson B.J. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 4 (2003) 974-981
144. Panettieri Jr. R.A. Airway smooth muscle: an immunomodulatory cell. J. Allergy Clin. Immunol. 110 (2002) S269-S274
145. Pascal L.E., and Tessier D.M. Cytotoxicity of chromium and manganese to lung epithelial cells in vitro. Toxicol. Lett. 147 (2004) 143-151
146. Pearlman D.S. Pathophysiology of the inflammatory response. J. Allergy Clin. Immunol. 104 (1999) S132-S137
147. Peiffer J.-L., Leon F., Tissier M.-H., Bonnet P.-A., Fabre I., and Ourlin J.-C. Comparison of MUTZ-3, THP-1 and U-937 cell lines as in vitro predictive models for contact sensitization. Toxicol. Lett. 172 (2007) S89-S90
148. Penna G., Vulcano M., Sozzani S., and Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 63 (2002) 1164-1171
149. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am. J. Respir. Cell Mol. Biol. 31 (2004) 3-7
150. Pichavant M., Charbonnier A.-S., Taront S., Brichet A., Wallaert B., Pestel J., Tonnel A.-B., and Gosset P. Asthmatic bronchial epithelium activated by the proteolytic allergen Der p 1 increases selective dendritic cell recruitment. J. Allergy Clin. Immunol. 115 (2005) 771-778
151. Pichowski J.S., Cumberbatch M., Dearman R.J., Basketter D.A., and Kimber I. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing. J. Appl. Toxicol. 21 (2001) 115-121
152. Pignatti P., Moscato G., Casarini S., Delmastro M., Poppa M., Brunetti G., Pisati P., and Balbi B. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways. J. Allergy Clin. Immunol. 115 (2005) 88
153. Potter D.W., and Wederbrand K.S. Total IgE antibody production in BALB/c mice after dermal exposure to chemicals. Fundam. Appl. Toxicol. 26 (1995) 127-135
154. Prussin C., and Metcalfe D.D. 5. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 117 (2006) S450-S456
155. Python F., Goebel C., and Aeby P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol. Appl. Pharmacol. 220 (2007) 113-124
156. Python F., Goebel C., and Aeby P. Genomic analysis of human monocyte derived dendritic-like cells and the human myeloid cell line MUTZ-3 exposed to cinnamaldehyde. Toxicol. Lett. 172 (2007) S91
157. Rattray N.J., Botham P.A., Hext P.M., Woodcock D.R., Fielding I., Dearman R.J., and Kimber I. Induction of respiratory hypersensitivity to diphenylmethane-4,4′-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicol 88 (1994) 15-30
158. Redlich C.A., and Karol M.H. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int. Immunopharmacol. 2 (2002) 213-224
159. Renauld J.C. New insights into the role of cytokines in asthma. J. Clin. Pathol. 54 (2001) 577-589
160. Richter M., Cantin A.M., Beaulieu C., Cloutier A., and Larivee P. Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L719-L729
161. Riffo-Vasquez Y., and Spina D. Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation. Pharmacol. Ther. 94 (2002) 185-211
162. Rippmann J.F., Schnapp A., Weith A., and Hobbie S. Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL-4/TNF[alpha] stimulated human epithelial cells. FEBS Lett. 579 (2005) 173-178
163. Ritz H.L., Evans B.L., Bruce R.D., Fletcher E.R., Fisher G.L., and Sarlo K. Respiratory and immunological responses of guinea pigs to enzyme-containing detergents: a comparison of intratracheal and inhalation modes of exposure. Fundam. Appl. Toxicol. 21 (1993) 31-37
164. Rizova H., Carayon P., Barbier A., Lacheretz F., Dubertret L., and Michel L. Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. Br. J. Dermatol. 140 (1999) 200-209
165. Robinson D., Hamid Q., Bentley A., Ying S., Kay A.B., and Durham S.R. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92 (1993) 313-324
166. Robinson M.K., Horn P.A., Kawabata T.T., Babcock L.S., Fletcher E.R., and Sarlo K. Use of the mouse intranasal test (MINT) to determine the allergenic potency of detergent enzymes: comparison to the guinea pig intratracheal (GPIT) test. Toxicol. Sci. 43 (1998) 39-46
167. Roche W.R., Beasley R., Williams J.H., and Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1 (1989) 520-524
168. Rosenwasser L.J. New immunopharmacologic approaches to asthma: role of cytokine antagonism. J. Allergy Clin. Immunol. 105 (2000) S586-S591
169. Rothen-Rutishauser B.M., Kiama S.G., and Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am. J. Respir. Cell Mol. Biol. 32 (2005) 281-289
170. Ryan C.A., Gildea L.A., Hulette B.C., Dearman R.J., Kimber I., and Gerberick G.F. Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicol. Lett. 150 (2004) 301-316
171. Ryan C.A., Gildea L.A., Hulette B.C., Dearman R.J., Kimber I., and Gerberick G.F. Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. Toxicol. Lett. 150 (2004) 301-316
172. Sakaguchi H., Ashikaga T., Miyazawa M., Yoshida Y., Ito Y., Yoneyama K., Hirota M., Itagaki H., Toyoda H., and Suzuki H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT) II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 20 (2006) 774-784
173. Sampson A.P. The role of eosinophils and neutrophils in inflammation. Clin. Exp. Allergy 30 Suppl. 1 (2000) 22-27
174. Sarlo K., and Clark E.D. A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals. Fundam. Appl. Toxicol. 18 (1992) 107-114
175. Sarlo K., Clark E.D., Ferguson J., Zeiss C.R., and Hatoum N. Induction of type I hypersensitivity in guinea pigs after inhalation of phthalic anhydride. J. Allergy Clin. Immunol. 94 (1994) 747-756
176. Sastre J., Vandenplas O., and Park H.S. Pathogenesis of occupational asthma. Eur. Respir. J. 22 (2003) 364-373
177. Schoeters E., Verheyen G.R., Nelissen I., Van Rompay A.R., Hooyberghs J., Van Den Heuvel R.L., Witters H., Schoeters G.E., Van Tendeloo V.F., and Berneman Z.N. Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol. Immunol. 44 (2007) 3222-3233
178. Schon-Hegrad M.A., Oliver J., McMenamin P.G., and Holt P.G. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 173 (1991) 1345-1356
179. Seed M.J., Cullinan P., and Agius R.M. Methods for the prediction of low molecular-weight occupational respiratory sensitizers. Curr. Opin. Allergy Clin. Mmunol. 8 (2008) 103-109
180. Selgrade M., Boykin E.H., Haykal-Coates N., Woolhiser M.R., Wiescinski C., Andrews D.L., Farraj A.K., Doerfler D.L., and Gavett S.H. Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicol. Sci. 94 (2006) 108-117
181. Smit J.J., and Lukacs N.W. A closer look at chemokines and their role in asthmatic responses. Eur. J. Pharmacol. 533 (2006) 277-288
182. Stellato C., Brummet M.E., Plitt J.R., Shahabuddin S., Baroody F.M., Liu M.C., Ponath P.D., and Beck L.A. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J. Immunol. 166 (2001) 1457-1461
183. Striz I., Slavcev A., Kalanin J., Jaresova M., and Rennard S.I. Cell-cell contacts with epithelial cells modulate the phenotype of human macrophages. Inflammation 25 (2001) 241-246
184. Szameit S., Vierlinger K., Farmer L., Tuschl H., and Noehammer C. Microarray-based in vitro test system for the discrimination of contact allergens and irritants: identification of potential marker genes. Clin. Chem. 54 (2008) 525-533
185. Tarlo S.M. Workplace respiratory irritants and asthma. Occup. Med. 15 (2000) 471-484
186. Tarlo S.M., and Broder I. Irritant-induced occupational asthma. Chest 96 (1989) 297-300
187. Tarlo S.M., and Liss G.M. Occupational asthma: an approach to diagnosis and management. Cmaj 168 (2003) 867-871
188. Teran L.M. CCL chemokines and asthma. Immunol. Today 21 (2000) 235-242
189. Toebak M.J., Pohlmann P.R., Sampat-Sardjoepersad S.C., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Rustemeyer T., and Gibbs S. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro 20 (2006) 117-124
190. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., and Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26 (1980) 171-176
191. Turato G., and Saetta M. Why does airway obstruction persist in asthma due to low-molecular-weight agents? A Pathologistis view. Occup. Med. 15 (2000) 445-454
192. Tuschl H., and Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol. In Vitro 15 (2001) 327-331
193. Tuschl H., Kovac R., and Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol. In Vitro 14 (2000) 541-549
194. van Kampen V., Merget R., and Baur X. Occupational airway sensitizers: an overview on the respective literature. Am. J. Ind. Med. 38 (2000) 164-218
195. Van Och F.M.M., Van Loveren H., De Jong W.H., and Vandebriel R.J. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol. Appl. Pharmacol. 184 (2002) 46
196. van Wetering S., Zuyderduyn S., Ninaber D.K., van Sterkenburg M.A., Rabe K.F., and Hiemstra P.S. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol. Immunol. 44 (2007) 803-811
197. Vandebriel R.J., De Jong W.H., Spiekstra S.W., Van Dijk M., Fluitman A., Garssen J., and Van Loveren H. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol. Appl. Pharmacol. 162 (2000) 77-85
198. Vandenplas O., and Malo J.L. Definitions and types of work-related asthma: a nosological approach. Eur. Respir. J. 21 (2003) 706-712
199. Venkatesha R.T., Berla Thangam E., Zaidi A.K., and Ali H. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol. Immunol. 42 (2005) 581-587
200. Verheyen G.R., Schoeters E., Nuijten J.M., Van Den Heuvel R.L., Nelissen I., Witters H., Van Tendeloo V.F., Berneman Z.N., and Schoeters G.E. Cytokine transcript profiling in CD34+progenitor derived dendritic cells exposed to contact allergens and irritants. Toxicol. Lett. 155 (2005) 187-194
201. Verrier A.C., Schmitt D., and Staquet M.J. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. Int. Arch. Allergy Immunol. 120 (1999) 56-62
202. Verstraelen S., Wens B., Hooyberghs J., Nelissen I., Witters H., Schoeters G., Cauwenberge P.V., and Heuvel R.V. Gene expression profiling of in vitro cultured macrophages after exposure to the respiratory sensitizer hexamethylene diisocyanate. Toxicol. In Vitro 22 (2008) 1107-1114
203. Wagner G.R., and Wegman D.H. Occupational asthma: prevention by definition. Am. J. Ind. Med. 33 (1998) 427-429
204. Wild L.G., and Lopez M. Occupational asthma caused by high-molecular-weight substances. Immunol. Allergy Clin. North Am. 23 (2003) 235-250
205. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., and Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
206. Wilson J.P., and Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Allergy 27 (1997) 363-371
207. Winton H.L., Wan H., Cannell M.B., Gruenert D.C., Thompson P.J., Garrod D.R., Stewart G.A., and Robinson C. Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability. Clin. Exp. Allergy 28 (1998) 1273-1285
208. Wisnewski A.V., and Redlich C.A. Recent developments in diisocyanate asthma. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 169-175
209. Wisnewski A.V., Srivastava R., Herick C., Xu L., Lemus R., Cain H., Magoski N.M., Karol M.H., Bottomly K., and Redlich C.A. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am. J. Respir. Crit. Care Med. 162 (2000) 2330-2336
210. Wolf M., Delgado M.B., Jones S.A., Dewald B., Clark-Lewis I., and Baggiolini M. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur. J. Immunol. 28 (1998) 164-170
211. Wong C.K., Wang C.B., Ip W.K., Tian Y.P., and Lam C.W. Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin. Exp. Immunol. 139 (2005) 90-100
212. Zeiss C.R. Advances in acid anhydride induced occupational asthma. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 89-92
213. Zhang X.D., Siegel P.D., and Lewis D.M. Immunotoxicology of organic acid anhydrides (OAAs). Int. Immunopharmacol. 2 (2002) 239-248
214. Zocca E., Fabbri L.M., Boschetto P., Plebani M., Masiero M., Milani G.F., Pivirotto F., and Mapp C.E. Leukotriene B4 and late asthmatic reactions induced by toluene diisocyanate. J. Appl. Physiol. 68 (1990) 1576-1580